Ceban, Felicia

Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis

Ceban, F., Ling, S., Lui, L. M. W., Lee, Y., Gill, H., Teopiz, K. M., Rodrigues, N. B., Subramaniapillai, M., Di Vincenzo, J. D., Cao, B., et al. (2022) · Brain, Behavior, and Immunity

Long-Term Effects of COVID-19COVID-19 Clinical Research Studies

Cited by 1,554

Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis

Alnefeesi, Y., Chen-Li, D., Krane, E., Jawad, M. Y., Rodrigues, N. B., Ceban, F., Di Vincenzo, J. D., Meshkat, S., Ho, R. C. M., Gill, H., et al. (2022) · Journal of Psychiatric Research

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 186

Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression

Ling, S., Ceban, F., Lui, L. M. W., Lee, Y., Teopiz, K. M., Rodrigues, N. B., Lipsitz, O., Gill, H., Subramaniapillai, M., Mansur, R. B., et al. (2022) · CNS Drugs

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 127

Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review

Cooper, D. H., Ramachandra, R., Ceban, F., Di Vincenzo, J. D., Rhee, T. G., Mansur, R. B., Teopiz, K. M., Gill, H., Ho, R., Cao, B., et al. (2023) · Journal of Psychiatric Research

Diabetes Treatment and ManagementTreatment of Major Depression

Cited by 79

The effect of ketamine on anhedonia: improvements in dimensions of anticipatory, consummatory, and motivation-related reward deficits

Nogo, D., Jasrai, A. K., Kim, H., Nasri, F., Ceban, F., Lui, L. M. W., Rosenblat, J. D., Vinberg, M., Ho, R., & McIntyre, R. S. (2022) · Psychopharmacology

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 54

Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials

Akbar, D., Rhee, T. G., Ceban, F., Ho, R., Teopiz, K. M., Cao, B., Subramaniapillai, M., Kwan, A. T. H., Rosenblat, J. D., & McIntyre, R. S. (2023) · CNS Drugs

Treatment of Major DepressionPsychological Treatments and Disorders

Cited by 38

Biomarkers of ketamine’s antidepressant effect: An umbrella review

Meshkat, S., Ho, R. C., Cao, B., Teopiz, K. M., Rosenblat, J. D., Rhee, T. G., Di Vincenzo, J. D., Ceban, F., Jawad, M. Y., & McIntyre, R. S. (2023) · Journal of Affective Disorders

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 29

Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatment

Doyle, M. A., Ling, S., Lui, L. M. W., Fragnelli, P., Teopiz, K. M., Ho, R., Di Vincenzo, J. D., Rosenblat, J. D., Gillissie, E. S., Nogo, D., et al. (2022) · Expert Opinion on Drug Safety

Psychedelics and Drug StudiesHallucinations in medical conditions

Cited by 27